{"id":842012,"title":"Archived 31: Summary of the NACI rapid response of January 28, 2022: Guidance on the use of booster COVID-19 vaccine doses in adolescents 12 to 17 years of age  - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-03-03","captureTimestamp":"2026-03-03T15:20:03.355000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/rapid-response-guidance-use-booster-covid-19-vaccine-doses-adolescents-12-17-years-age/summary.html","snippet":"Archived 31: Summary of the NACI rapid response of January 28, 2022: Guidance on the use of booster COVID-19 vaccine doses in adolescents 12 to 17 years of age Notice to reader This is an archived version. Please refer to current COVID-19 vaccine pages: NACI statements and…","rawSnapshotUrl":"/api/snapshots/raw/842012","browseUrl":"https://replay.healtharchive.ca/job-7/20260303152003/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/rapid-response-guidance-use-booster-covid-19-vaccine-doses-adolescents-12-17-years-age/summary.html#ha_snapshot=842012","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}